See the new infographic for changes to the 2026 Medicare Part D program
...Category Archives: Advocacy
2026 MAPRx Medicare Open Enrollment Guide
The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2025 – December 7, 2025 for coverage beginning January 1, 2026. Plans make changes to benefits and costs, and there are also many new changes for the 2026 plan year.
MAPRx encourages both new and existing...
MAPRx Comments on Medicare Drug Price Negotiation Program
The MAPRx Coalition submitted comments to CMS urging that as the MDPNP is implemented, it is imperative that the program is informed by the experiences and needs of beneficiaries living with
chronic diseases and conditions. Read for more.
2026 Part D Proposed Rule Comments
MAPx appreciates the opportunity to comment on specific provisions in the CY 2026 policy and technical changes to MA and Part D. Read the Comment Letter
...Briefing Memo: “Protected Classes”
The Medicare Access for Patients Rx (MAPRx) Coalition, comprised of more than fifty-five beneficiary advocacy organizations, urges the Centers for Medicare and Medicaid Services (CMS) to reverse its proposed policy changes to the Medicare Part D six “protected classes.” Proposed changes will limit access to medications under the Part D benefit for...
THE MAPRx COALITION CELEBRATES 10 YEAR ANNIVERSARY OF MEDICARE PART D
Letter to Congress applauds Medicare coverage of drugs, new report highlights economic impact
WASHINGTON, D.C., December 3, 2013 – The Medicare Access for Patients Rx Coalition (MAPRx) today distributed a letter and a report to Congress signed by 53 national advocacy organizations thanking members for...April 2013 Letter to Congress
Dear Members of Congress:
Medicare Access for Patients RX or MAPRx brings together national beneficiary, patient advocacy, family caregiver, and health professional organizations committed to ensuring and improving access to prescription medications and safeguarding the well-being of beneficiaries with chronic diseases and disabilities under the Medicare prescription drug benefit (Part D). On behalf of millions of...
Read more
MAPRx Letter to Acting CMS Administrator Marilyn Tavenner
Ms. Marilyn Tavenner
Acting Administrator
Centers for Medicare and Medicaid Services
7500 Security Boulevard
Baltimore, Maryland 21244
Re: Draft 2014 Call Letter for the Medicare Advantage (MA) and Prescription Drug Programs
Dear Acting Administrator Tavenner:
On behalf of millions of Medicare beneficiaries with chronic diseases and conditions who rely on Medicare Part D for essential medications, MAPRx appreciates the opportunity...
Read more
Letter to Congress Re: Drug Benefit Design
Dear Member of Congress –
MAPRx brings together beneficiary, patient advocacy, family caregiver and health professional organizations committed to improving access to prescription medications and safeguarding the well being of beneficiaries with chronic diseases and disabilities under the Medicare prescription drug benefit (Part D). On behalf of millions of Medicare beneficiaries with chronic conditions who rely...
Read more
October 2012 Briefing on Capitol Hill
